Cj. Ormandy et al., AMPLIFICATION, EXPRESSION, AND STEROID REGULATION OF THE PREPROGALANIN GENE IN HUMAN BREAST-CANCER, Cancer research, 58(7), 1998, pp. 1353-1357
The GALN gene encodes the preprogalanin protein that is cleaved to lib
erate the galanin peptide, a neuropeptide and tumor cell mitogen, and
the galanin message-associated peptide, which is of unknown function,
GALN is located at chromosome 11q13, a frequently amplified locus in d
iverse tumor types including breast cancer, To determine whether GALN
may contribute to the tumor phenotype resulting from 11q13 amplificati
on, we examined GALN amplification and preprogalanin mRNA levels in br
east tumors and cell lines, GALN was amplified in a subset of breast t
umors and cell lines that carried 11q13 amplifications, Preprogalanin
mRNA was expressed in the majority of breast cancer cell lines, but No
rthern analysis failed to demonstrate a relationship between GALN ampl
ification and preprogalanin mRNA levels, Eight of eight estrogen recep
tor-positive cell lines expressed detectable preprogalanin mRNA, and f
urther investigation showed that preprogalanin mRNA was increased by t
reatment with estradiol and progestin and decreased by the removal of
serum or treatment with antiestrogens, Thus, GALN amplification is unl
ikely to contribute to the phenotype conferred by 11q13 amplification
in breast cancer, but preprogalanin mRNA is expressed by breast cancer
cells and is under steroid hormone control in estrogen receptor-posit
ive cells, opening the wider question of the role of this steroid-regu
lated neuropeptide in the normal and cancerous breast.